Investor Update
Logotype for Essity

Essity (ESSITY) Investor Update summary

Event summary combining transcript, slides, and related documents.

Logotype for Essity

Investor Update summary

16 Jun, 2026

New Financial Targets and Capital Allocation

  • Set new annual organic sales growth target above 3% and EBITA margin above 15%, both higher than previous targets, reflecting increased ambition after the Vinda divestment.

  • Share buyback program of SEK 3 billion to begin June 17, 2024, and run until AGM 2025, intended as a recurring capital allocation tool funded by strong operating cash flow.

  • Financial policies remain unchanged, with a focus on maintaining a solid investment grade rating and stable, rising dividends.

  • Previous ROCE target replaced by the new EBITA margin focus, with acquisitions excluded from the annual growth target.

Strategic Focus and Market Outlook

  • Emphasis on growth in high-margin, less capital-intensive categories, leveraging strong market positions and brands.

  • Market trends are favorable, driven by higher living standards, aging populations, increased health awareness, and chronic conditions, supporting growth in all business segments.

  • Growth strategy includes increased A&P investment, innovation, and a focus on superior product offerings.

  • Exposed to global market growth rates of 2–4%, with Health & Medical and Asia showing higher growth potential.

  • Portfolio optimized for efficiency, lower volatility, and increased pricing power, with strong financial position and attractive dividend/EPS growth.

Margin Improvement and Operational Efficiency

  • Margin improvement to be achieved through operating leverage, cost focus, premiumization, innovation, and organic portfolio changes, not further divestments.

  • Incentive programs have shifted to prioritize growth alongside margin protection, with changes already implemented for 2024.

  • Efficiency gains and a balanced product portfolio support the margin target, with over 36% of costs fixed, enabling scale benefits.

  • Roadmap to EBITA margin target includes product mix improvement, innovation, efficiency gains, and operating leverage.

  • Emphasis on profitable growth, market share gains, and improved profitability through innovation and efficiency.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more